MNDY vs SYNA

MNDY exhibits exceptional fundamental health with a perfect Piotroski F-Score of 9/9 and a very low Debt/Equity ratio of 0.14. While the stock has suffered a severe technical collapse over the last year (-74.9%), the valuation is now highly attractive with a PEG ratio of 0.28 and a Forward P/E of 12.26. The current price of $61.69 aligns closely with the growth-based intrinsic value of $66.08, suggesting a significant margin of safety relative to analyst targets of $125.76. The combination of 89.2% gross margins and consistent earnings beats makes this a high-conviction fundamental play despite the bearish price action.

Synaptics (SYNA) presents a stark contrast between poor deterministic health and strong growth valuation. The Piotroski F-Score of 2/9 indicates weak financial health and deteriorating fundamentals, further evidenced by negative profit margins and ROE. However, the company exhibits strong growth momentum with a PEG ratio of 0.51 and a consistent track record of earnings beats over 25 quarters. While liquidity remains robust (Current Ratio 2.93), the combination of insider selling and a weak health score offsets the bullish analyst targets and recent price appreciation.